Cues specifically unpaired with amphetamine attenuate the development of locomotor sensitization to the D-2 dopamine receptor agonist quinpirole
Jake Matthews, C.; Vezina, P.
Society for Neuroscience Abstracts 21(1-3): 2089
1995
ISSN/ISBN: 0190-5295 Accession: 030758117
PDF emailed within 1 workday: $29.90
Related References
Perreault, M.L.; Graham, D.; Scattolon, S.; Wang, Y.; Szechtman, H.; Foster, J.A. 2007: Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats Psychopharmacology 194(4): 485-496Lomanowska, A.; Gormley, S.; Szechtman, H. 2004: Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 77(3): 617-622
Johnson, E.F.; Szechtman, H. 2016: A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity Behavioural Pharmacology 27(5): 439-450
Jung, T.D.; Jung, P.S.; Raveendran, L.; Farbod, Y.; Dvorkin-Gheva, A.; Sakic, B.; Surette, M.G.; Szechtman, H. 2018: Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole Behavioural Pharmacology 29(2 and 3-Spec Issue): 211-224
Einat, H..; Szechtman, H.. 1993: Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole Behavioural Pharmacology 4(4): 399-403
Beerepoot, P.; Lam, V.; Luu, A.; Tsoi, B.; Siebert, D.; Szechtman, H. 2008: Effects of Salvinorin A on Locomotor Sensitization to D2/D3 Dopamine Agonist Quinpirole Neuroscience Letters 446(2-3): 101-104
Einat, H.; Einat, D.; Allan, M.; Talangbayan, H.; Tsafnat, T.; Szechtman, H. 1996: Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole Psychopharmacology 127(2): 95-101
Jang, J.K.; Kim, W.Y.; Cho, B.R.; Lee, J.W.; Kim, J.-H. 2018: Locomotor sensitization is expressed by ghrelin and D1 dopamine receptor agonist in the nucleus accumbens core in amphetamine pre-exposed rat Addiction Biology 23(3): 849-856
Szechtman, H.; Dai, H.; Mustafa, S.; Einat, H.; Sullivan, R.M. 1994: Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 48(4): 921-928
Muscat, R.; Iravani, M.M.; Kruk, Z.L. 1996: The role of ventral tegmental dopamine neurons in locomotor sensitization following quinpirole or (+)-amphetamine: ex vivo voltammetric evidence Neuroscience 75(4): 1175-1184
Culver, K.E.; Szechtman, H. 1999: The effect of intermittent and continuous clorgyline administration on locomotor sensitization induced by the dopamine agonist quinpirole Society for Neuroscience Abstracts 25(1-2): 1214
Richtand, N.M.; Logue, A.D.; Welge, J.A.; Perdiue, J.; Tubbs, L.J.; Spitzer, R.H.; Sethuraman, G.; Geracioti, T.D. 2000: The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine Brain Research 867(1-2): 239-242
Vezina, P.; Stewart, J. 1989: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine Brain Research 499(1): 108-120
Escobar, A.él.P.; González, M.P.; Meza, R.C.; Noches, V.ón.; Henny, P.; Gysling, K.; España, R.A.; Fuentealba, J.é A.; Andrés, M.ía.E. 2017: Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats International Journal of Neuropsychopharmacology 20(8): 660-669
Escobar, Aélica.del.Pilar.; Cornejo, F.Alejandra.; Andrés, Mía.Estela.; Fuentealba, Jé.Antonio. 2012: Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K+ induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats Neurochemistry International 60(4): 344-349